Akari Therapeutics Plc (AKTX) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
401 EAST JACKSON STREET TAMPA, FL 33602 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
| 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2,711,000 | 2,582,000 | 2,599,000 | 2,246,000 | 4,177,000 | 1,310,000 | |||
| Cash and cash equivalent | 2,711,000 | 2,582,000 | 2,599,000 | 2,246,000 | 4,177,000 | 1,310,000 | |||
| Prepaid expense | 447,000 | 627,000 | 92,000 | 396,000 | 805,000 | 1,230,000 | |||
| Other current assets | 83,000 | 80,000 | 201,000 | 92,000 | 94,000 | 232,000 | |||
| Other undisclosed current assets | 60,000 | 60,000 | 60,000 | ||||||
| Total current assets: | 3,301,000 | 3,349,000 | 2,952,000 | 2,734,000 | 5,076,000 | 2,772,000 | |||
| Noncurrent Assets | |||||||||
| Intangible assets, net (including goodwill) | 47,610,000 | 47,610,000 | 47,610,000 | ||||||
| Goodwill | 8,430,000 | 8,430,000 | 8,430,000 | ||||||
| Intangible assets, net (excluding goodwill) | 39,180,000 | 39,180,000 | 39,180,000 | ||||||
| Total noncurrent assets: | 47,610,000 | 47,610,000 | 47,610,000 | ||||||
| TOTAL ASSETS: | 50,911,000 | 50,959,000 | 50,562,000 | 2,734,000 | 5,076,000 | 2,772,000 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 14,075,000 | 16,561,000 | 15,544,000 | 7,387,000 | 6,371,000 | 4,738,000 | |||
| Accounts payable | 11,607,000 | 13,067,000 | 12,407,000 | 4,782,000 | 4,686,000 | 3,208,000 | |||
| Accrued liabilities | 2,468,000 | 3,494,000 | 3,137,000 | 2,605,000 | 1,685,000 | 1,530,000 | |||
| Debt | 179,000 | 228,000 | 659,000 | 200,000 | 600,000 | ||||
| Restructuring reserve | 458,000 | ||||||||
| Other liabilities | 650,000 | 484,000 | 94,000 | 316,000 | 653,000 | 983,000 | |||
| Other undisclosed current liabilities | 2,234,000 | 3,634,000 | 3,613,000 | 1,525,000 | 697,000 | 604,000 | |||
| Total current liabilities: | 17,138,000 | 20,907,000 | 19,910,000 | 9,428,000 | 8,779,000 | 6,325,000 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 8,168,000 | 8,306,000 | 8,423,000 | ||||||
| Deferred income tax liabilities | 8,040,000 | 8,040,000 | 8,040,000 | ||||||
| Other liabilities | 128,000 | 266,000 | 383,000 | ||||||
| Derivative instruments and hedges, liabilities | |||||||||
| Total noncurrent liabilities: | 8,168,000 | 8,306,000 | 8,423,000 | ||||||
| Total liabilities: | 25,306,000 | 29,213,000 | 28,333,000 | 9,428,000 | 8,779,000 | 6,325,000 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 25,605,000 | 21,746,000 | 22,229,000 | (6,694,000) | (3,703,000) | (3,553,000) | |||
| Common stock | 6,523,000 | 5,776,000 | 5,319,000 | 2,430,000 | 2,430,000 | 1,598,000 | |||
| Additional paid in capital | 220,846,000 | 215,506,000 | 212,706,000 | 183,088,000 | 183,007,000 | 176,443,000 | |||
| Accumulated other comprehensive loss | (1,106,000) | (773,000) | (738,000) | (926,000) | (749,000) | (761,000) | |||
| Accumulated deficit | (252,852,000) | (250,957,000) | (247,252,000) | (243,480,000) | (240,585,000) | (233,027,000) | |||
| Other undisclosed equity, attributable to parent | 52,194,000 | 52,194,000 | 52,194,000 | 52,194,000 | 52,194,000 | 52,194,000 | |||
| Total equity: | 25,605,000 | 21,746,000 | 22,229,000 | (6,694,000) | (3,703,000) | (3,553,000) | |||
| TOTAL LIABILITIES AND EQUITY: | 50,911,000 | 50,959,000 | 50,562,000 | 2,734,000 | 5,076,000 | 2,772,000 | |||
Income Statement (P&L) (USD)Annual | Quarterly
| 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (3,119,000) | (3,525,000) | (7,001,000) | (2,844,000) | (5,809,000) | (5,989,000) | ||
| Other undisclosed operating income (loss) | 1,723,000 | (83,000) | (1,640,000) | |||||
| Operating loss: | (3,119,000) | (3,525,000) | (5,278,000) | (2,927,000) | (7,449,000) | (5,989,000) | ||
| Nonoperating income (expense) | 1,224,000 | (180,000) | 1,506,000 | 32,000 | (109,000) | 423,000 | ||
| Gain (loss), foreign currency transaction, before tax | (50,000) | 27,000 | 6,000 | 68,000 | 91,000 | |||
| Interest and debt expense | (50,000) | 54,000 | (124,000) | (69,000) | (51,000) | |||
| Loss from continuing operations before equity method investments, income taxes: | (1,945,000) | (3,651,000) | (3,896,000) | (2,964,000) | (7,609,000) | (5,566,000) | ||
| Other undisclosed income from continuing operations before income taxes | 244,000 | |||||||
| Loss from continuing operations before income taxes: | (1,945,000) | (3,651,000) | (3,652,000) | (2,964,000) | (7,609,000) | (5,566,000) | ||
| Income tax benefit | ||||||||
| Net loss: | (1,945,000) | (3,651,000) | (3,652,000) | (2,964,000) | (7,609,000) | (5,566,000) | ||
| Other undisclosed net income (loss) attributable to parent | 50,000 | (54,000) | (120,000) | 69,000 | 51,000 | |||
| Net loss available to common stockholders, diluted: | (1,895,000) | (3,705,000) | (3,772,000) | (2,895,000) | (7,558,000) | (5,566,000) | ||
Comprehensive Income (USD)Annual | Quarterly
| 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (1,945,000) | (3,651,000) | (3,652,000) | (2,964,000) | (7,609,000) | (5,566,000) | ||
| Other comprehensive income (loss) | (333,000) | (35,000) | (177,000) | 12,000 | 279,000 | |||
| Other undisclosed comprehensive income | 302,000 | |||||||
| Comprehensive loss: | (2,278,000) | (3,686,000) | (3,350,000) | (3,141,000) | (7,597,000) | (5,287,000) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 50,000 | (54,000) | (234,000) | 69,000 | 51,000 | |||
| Comprehensive loss, net of tax, attributable to parent: | (2,228,000) | (3,740,000) | (3,584,000) | (3,072,000) | (7,546,000) | (5,287,000) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.